Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew MacGregor Cameron

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA Surgery|August 3, 2022
Just How Low a Model for End-stage Liver Disease Score Benefits From Living-Donor Liver Transplant?Andrew MacGregor Cameron
Annals of Surgery|March 24, 2021
Commentary on "Making Every Liver Count"Andrew MacGregor Cameron
The Journal of Clinical Investigation|July 15, 2022
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failureJing Ma, Adrien Guillot, Zhihong Yang, et al.
JCI Insight|May 18, 2021
Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinomaLing Li, Gilad Halpert, Michael G Lerner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA Surgery|August 3, 2022
Just How Low a Model for End-stage Liver Disease Score Benefits From Living-Donor Liver Transplant?Andrew MacGregor Cameron
Annals of Surgery|March 24, 2021
Commentary on "Making Every Liver Count"Andrew MacGregor Cameron
The Journal of Clinical Investigation|July 15, 2022
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failureJing Ma, Adrien Guillot, Zhihong Yang, et al.
JCI Insight|May 18, 2021
Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinomaLing Li, Gilad Halpert, Michael G Lerner, et al.
Pageof 1